Suanfarma launches €30m biotech fund

The vehicle aims to raise €30m to invest in 10-15 start-up firms.

It follows on from Suanfarma's first fund, Suan Biotech, which closed on €9m and has supported seed-stage businesses such as Vivia Biotech, 3P Biopharmaceuticals, Pevesa, Salupharma Biosimilars, Clave Suan, Biomedal, Agrenvec and Halotech.

The unquote" team is currently researching this fund. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Susannah Birkwood on +44 20 7004 7524 or susannah.birkwood@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Venture
• Technology
• Southern Europe